Skip to main content
. 2014 Feb 13;2014(2):CD008639. doi: 10.1002/14651858.CD008639.pub2

Schadler 2012.

Methods  
Participants Patients ventilated for > 9 hours at 9:00 am in three ICUs (cardiovascular, interdisciplinary, surgical) serving all surgical disciplines in an academic tertiary hospital. Most patients were included following elective or emergency surgery with small numbers of patients included preoperatively or for non‐surgical reasons. In subgroup analysis, they examined patients who underwent cardiac surgery (n=132), and with sepsis (n=44) or chronic obstructive pulmonary disease (n=41)
Interventions SmartCare™ versus weaning based on standardized written protocol
Outcomes Discontinuation time (time from randomization to extubation)
Time to successful extubation
Time to first SBT
Time to first successful SBT
Total duration of mechanical ventilation (initiation to extubation)
ICU length of stay
Hospital length of stay
Mortality ‐ 28 day
Mortality ‐ 90 day
Use of non‐invasive ventilation following extubation
Adverse event ‐ reintubation
Adverse event ‐ self‐extubation
Adverse event ‐ tracheostomy
Prolonged mechanical ventilation > 14 days
Prolonged mechanical ventilation > 21 days
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk An electronic randomization system was used to generate randomization lists
Allocation concealment (selection bias) Low risk Allocation reported to be concealed and allocation was disclosed to investigators by sealed envelopes containing patient numbers such that patient one received study envelope one
Incomplete outcome data (attrition bias) 
 All outcomes Low risk The authors randomized 317 patients for which consent could not be obtained in 17 patients. Reported analyses included all 300 randomized patients for which consent was obtained. Withdrawals by treatment group were not reported
Selective reporting (reporting bias) Low risk No evidence of selective outcome reporting
Did the trial stop early for benefit? Low risk Trial did not stop early for benefit
Participants analysed according to the group allocated to? Low risk Yes